Steroid Receptor Levels in Breast Cancer: Relationships with Age and menopausal status

References

• Hawkins R. A, Roberts M. M, Forrest A. PM. Oestrogen receptors in breast cancer: Current status. Br J Surg 1980; 67: 153–69
   PubMedGoogle Scholar
• Jensen E. V, Block G. E, Smith S., De Sombre E. Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monograph 1971; 34: 55–70
   PubMedGoogle Scholar
• Knight W. A, Livingston R. B, Gregory E. J, McGuire WL. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 1977; 37: 4669–73
   PubMed Web of Science ®Google Scholar
• McGuire WL. Hormone receptors: Their role in predicting prognosis and response to endocrine therapy. Semin Oncol 1978; 5: 428–33
   PubMed Web of Science ®Google Scholar
• Clark G. M, McGuire WL. Progesterone receptors and human breast cancer. Breast Cancer Res Treat 1983; 3: 157–63
   PubMed Web of Science ®Google Scholar
• Theve N. O, Carlström K., Gustafsson JÅ, et al. Oestrogen receptors and peripheral serum levels of oestradiol-17β in patients with mammary carcinoma. Eur J Cancer 1978; 14: 1337–40
   Google Scholar
• Clark G. M, Osborne C. K, McGuire WL. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 1984; 2: 1102–9
   PubMed Web of Science ®Google Scholar
• McCarty KS., Jr, Silva J. S, Edwin B. C, Leight G. S, Wells S. A, McCarty KS, Sr. Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. Ann Surg 1983; 197: 123–7
   PubMedGoogle Scholar
• Fisher B., Wickerman D. L, Brown A., Redmond C. K, et al. Breast cancer estrogen and progesterone values: Their distribution, degree of concordance, and relation to number of positive axillary nodes. J Clin Oncol 1983; 1: 349–58
   PubMedGoogle Scholar
• Mattsson B., Rutqvist L. E, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 1985; 14: 64–9
   PubMed Web of Science ®Google Scholar
• Fernö M., Borg Å., Sellberg G. Enzyme immuno assay of estrogen receptor in breast cancer biopsy samples. A comparison with isoelectric focusing. Acta Radiol Oncol 1986; 25: 171–6
   PubMed Web of Science ®Google Scholar
• Wrange Ö., Nordenskjöld B., Gustafsson J-Å. Cytosol estradiol receptor in human mammary carcinoma. An assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem 1978; 85: 416–21
   Web of Science ®Google Scholar
• Wrange Ö., Humla S., Ramberg I., et al. Progestin-receptor analysis in human breast cancer cytosol by isoelectric focusing in slabs of polyacrylamide gel. J Steroid Biochem 1981; 14: 141–8
   PubMedGoogle Scholar
• Macias A., Perez R., Hägerström T., Skoog L. Identification of transforming growth factor alfa in human primary breast carcinomas. Anticancer Res 1987; 7: 1271–6
   PubMedGoogle Scholar
• Perez R., Pascual M. R, Macais A., Lage A. Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 1984; 4: 189–93
   PubMed Web of Science ®Google Scholar
• Salmon E. D, Zwiebel A. J, Bano M. M, Losonczy I. L, Fehnel P., Kidwell WR. Presence of transforming growth factors in human breast scanner cells. Cancer Res 1984; 44: 4069–77
   PubMedGoogle Scholar
• Skoog L., Macias A., Azavedo E., Lombardero J., Klintenberg C. Receptors for EGF and estradiol and thymidine kinase activity in different histological subgroups of human mammary carcinomas. Br J Cancer 1986; 54: 271–6
   PubMed Web of Science ®Google Scholar
• Fallenius A. G, Skoog L. K, Svane G. E, Auer GU. Cytophoto-metrical and biochemical characterization of nonpalpable, mammographically detected mammary adenocarcinomas. Cytometry 1984; 5: 426–9
   PubMedGoogle Scholar
• Bertuzzi A., Daidone M. G, Di Fronzo G., Silvestrini R. Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. Breast Cancer Res Treat 1981; 1: 253–62
   PubMedGoogle Scholar
• Saez S., Martin P. M, Chouvet CD. Estradiol and progesterone levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels. Cancer Res 1978; 38: 3468–73
   PubMed Web of Science ®Google Scholar
• Wilking N., Carlström K., Gustafsson S. A, Sköldefors H., Tollbom Ö. Oestrogen receptors and metabolism of oestrone sulphate in human mammary carcinoma. Eur J Cancer 1980; 16: 1339–44
   PubMed Web of Science ®Google Scholar
• Degenshein G. A, Bloom N., Tobin E. The value of progesterone receptor assays in the management of advanced breast cancer. Cancer 1976; 46: 2789–93
   Google Scholar